Magnitude of Serosal Changes Predicts Peritoneal Recurrence of Gastric Cancer
Authors:
- Taichi KawamuraTKTaichi Kawamura
- Kazuo KinoshitaKKKazuo Kinoshita
- Shigeru TakahashiSTShigeru Takahashi
- Atsuyuki MaedaAMAtsuyuki Maeda
- Shunichi OsadaSOShunichi Osada
- Yasuhiro TsubosaYTYasuhiro Tsubosa
- Shigeki YamaguchiSYShigeki Yamaguchi
- Katsuhiko UesakaKUKatsuhiko Uesaka
- Yutaka YonemuraYYYutaka Yonemura
- 1 August 2003
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 197 (2) , 212-222
Abstract
Peritoneal dissemination is the most frequent mode of recurrence in patients with gastric cancer. We tried to identify factors that predict peritoneal recurrence with high sensitivity. Clinical and pathologic data from 587 consecutive patients with gastric cancer were reviewed retrospectively. The stepwise Cox proportional hazards regression model was used to assess the prognostic significance of the magnitude of serosal changes. Multiple stepwise logistic regression analysis was used to determine factors associated with peritoneal recurrence in 375 patients who underwent curative resection. The 5-year survival rate of patients with S2 disease (greatest dimension of macroscopic serosal changes >/= 2.5 cm) was 18%, which was worse than S0 (no serosal changes) and S1 disease (macroscopic serosal changes < 2.5 cm)(p < 0.001). Patients with S0 tumors who underwent curative resection had the best 5-year survival rate. Multivariate analyses indicated that the magnitude of serosal changes was an independent prognostic factor for survival both overall and after curative resection. Logistic regression analysis showed that peritoneal recurrence was more than four times as likely with S2 than with S0 or S1 tumors. The sensitivity for predicting peritoneal recurrence was 79%; the sensitivity of cytologic examination was 38%. Magnitude of serosal changes is easy to measure intraoperatively and predicts peritoneal recurrence of gastric cancer with greater sensitivity than conventional peritoneal lavage cytology.Keywords
This publication has 43 references indexed in Scilit:
- Integrin α6β4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancerGastroenterology, 2000
- Detection of Carcinoembryonic Antigen‐expressing Free Tumor Cells in Peritoneal Washes from Patients with Gastric Carcinoma by Polymerase Chain ReactionJapanese Journal of Cancer Research, 1997
- Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal disseminationInternational Journal of Cancer, 1996
- Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled studyCancer, 1994
- Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurgical Oncology, 1992
- Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival timeCancer, 1992
- Hyperthermo‐chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal disseminationWorld Journal of Surgery, 1991
- Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin CCancer, 1988
- The Most Important Prognostic Factors for Gastric Cancer Patients: A Study Using Univariate and Multivariate AnalysesScandinavian Journal of Gastroenterology, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958